Virtus LifeSci Biotech Products ETF
ETFYour view on BBP
Virtus LifeSci Biotech Products ETF
ETFVirtusSentiment
AUM (USD)
$124.04M
Expense Ratio
0.34%
Holdings
198
Sentiment
Overview for Virtus LifeSci Biotech Products ETF
- Fund Type
- ETF
- Fund Issuer
- Virtus
- Asset Class
- Sector Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 16, 2014
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Virtus
- Asset Class
- Sector Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 16, 2014
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Virtus
- Asset Class
- Sector Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 16, 2014
- Domicile
- US
About this fund
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.
BBP Stock Price
Key Facts
Sector EquityExpense Ratio
0.34%
AUM
$124.04M
Fund Details
Expense Ratio
0.34%
Assets Under Management
$124.04M
NAV
$103.36 USD
Holdings
198
Average Volume
10.4K
Inception Date
December 16, 2014
Asset Class
Sector Equity
Fund Issuer
Virtus
Domicile
US
ISIN
US26923G2021
CUSIP
26923G202
NAV Currency
USD
Expense Ratio
0.34%
Assets Under Management
$124.04M
NAV
$103.36 USD
Holdings
198
Average Volume
10.4K
Inception Date
December 16, 2014
Asset Class
Sector Equity
Fund Issuer
Virtus
Domicile
US
ISIN
US26923G2021
CUSIP
26923G202
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.